Cape Investment Advisory, Inc. Bristol Myers Squibb CO Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 413 shares of BMY stock, worth $25,188. This represents 0.01% of its overall portfolio holdings.
Number of Shares
413
Previous 375
10.13%
Holding current value
$25,188
Previous $19.4 Million
20.48%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,767Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.8 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...